A recent analysis from Biomedtracker of clinical trial phase transitions between 2014 and 2023 suggests biopharma development success rates are falling. This poses several questions: what are the underlying reasons dragging success rates down and what does this mean for R&D productivity and the return on investment on pipeline spend? https://lnkd.in/ezX4Dsmb Citeline Commercial #biopharma #clinicaltrials #RnD
Lucie Ellis-Taitt’s Post
More Relevant Posts
-
Grey Wolf Therapeutics has secured $99m via an expanded series B financing to advance its antigen modulation approach in cancer and to further explore its use in autoimmune disease indications. “Grey wolf’s approach to enhance tumor cell visibility by upregulation of neoantigens could prove particularly useful in ‘hot’ tumor cancer types which are burdened with high relapse rates due to T-cell exhaustion, for example melanoma.” Citeline Commercial #biotech #cancer #researchdevelopment #biopharma
‘Potentially Groundbreaking’ – Grey Wolf Advances IO Technology
invivo.citeline.com
-
"I have to go beyond just focusing on bringing medicines to patients but also start looking at what health care systems really need." Check out the latest In Vivo podcast episode with AstraZeneca's Stefan Woxström, senior VP, Europe and Canada. https://lnkd.in/dmKMy_VU Citeline Commercial #pharma #biotech #healthcare
-
-
Took me a while!
The answer last week was PENICILLIN! (🖊pen-is- 😎chilling) - thanks to Annabel Griffiths for the image! Here's another #namethatdrug and I think it's a really easy one 💊 Rules: - LIKE this post if you're having a go - Using your code-cracking skills, guess the DRUG hinted by the emojis below. - It might not be so literal - think of drug names, think what the emojis are (or sound like!) - and have a go - MESSAGE ME me your answer so other people can keep playing - The prize is being in the Winners' Circle for the week. WINNERS' CIRCLE FROM LAST WEEK: Lya Rebelo Eliza Slawther Lya Rebelo Maire Gerrard Zhyar Said Matt S. Daniel Hoopes Bryce Mitchell Charlotte Mackey Andreas Friberg Lizzie Walker Danielle Adamson Neal Curtis Vince Spurr (think that's everyone) Name that DRUG! (NOT #namethatpharma)
-
-
Catch up on new episodes of the In Vivo Podcast: https://lnkd.in/gAgSdiHF In the latest episode, Claus Zieler, chief commercial officer at Astellas Pharma, puts out a call to action for industry to better collaborate with regulators to improve access to medicines in a more efficient manner. https://lnkd.in/gGCs2k3e #pharma Astellas Pharma #biotech #healthcare Citeline Commercial
-
After decades of lackluster start-up #innovation despite award-winning science, Japan’s government and big pharma players are taking steps to spur #biotech growth.
Japan’s Biotech Ecosystem Could Be Headed For An Upswing
invivo.citeline.com
-
Something a bit different on Scrip! The German group has spent much of the year reviewing the pros and cons of its hybrid structure but there was never any question about divesting Bayer 04 Leverkusen, its extremely successful football team, CEO Bill Anderson told journalists.
Bayer Revels In Its Football Club's Remarkable Run
scrip.citeline.com
-
#BioBytes presents an overview of #AI-related #biopharma deals in Q1 2024. This is the first in a recurring series of quarterly deal updates. Free to view. https://lnkd.in/d2h37NxG
BioBytes: AI-Related Deals In Q1 2024
invivo.citeline.com
